Log In
Print this Print this

naloxone (Nalcol)

  Manage Alerts
Collapse Summary General Information
Company S.L.A. Pharma AG
DescriptionSlow-release, oral formulation of naloxone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationConstipation
Indication DetailsTreat opioid-induced constipation (OIC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today